Background-Genome-wide association studies have identified single-nucleotide polymorphisms (SNPs) for subclinical cardiovascular outcomes in adults. We examined the influence of these variants on the same outcomes in childhood. Methods and Results-In a population-based prospective cohort study among 4137 children, we examined the associations of SNPs, individually and incorporated in genetic risk scores, which were identified in adults for cardiac (2 SNPs for left ventricular end-diastolic diameter and 5 SNPs for aortic root diameter) and blood pressure outcomes (29 SNPs for systolic and diastolic blood pressure, 22 SNPs for mean arterial pressure, and 10 SNPs for pulse pressure) with the same outcomes in children (median age of 6.0 years [95% range, 4.5-8.7]). Weighted and unweighted risk scores for aortic root diameter were associated with childhood aortic root diameter (difference per additional average risk allele 0.09 mm [95% CI: 0.05, 0.13]). Weighted and unweighted risk scores for pulse pressure were associated with childhood pulse pressure (difference per additional average risk allele 0.22 mm Hg [95% CI: 0.08, 0.35] and 0.18 mm Hg [95% CI: 0.05, 0.31], respectively), but not with childhood systolic or diastolic blood pressure or mean arterial pressure. The risk scores for blood pressure and mean arterial pressure were not associated with any of the childhood blood pressure outcomes. Conclusions-Genetic risk scores based on SNPs for aortic root diameter and pulse pressure in adults are associated with the same outcomes in children. SNPs related to cardiovascular outcomes in adulthood at least partly influence cardiovascular development from early life onwards.
S ubclinical cardiovascular risk factors, such as increased blood pressure and left cardiac structural changes, develop from childhood onwards and are known to cluster in families. [1] [2] [3] [4] Although lifestyle and environmental factors strongly contribute to the development of cardiovascular disease throughout the life course, genetic factors also play an important role. Heritability estimates range from 30% for left ventricular mass, 36% for left ventricular end-diastolic diameter (LVEDD), 44% for aortic root diameter (AoD) to 57% for blood pressure. [5] [6] [7] [8] [9] [10] 
Clinical Perspective on p 602
Recent genome-wide association studies (GWAS) have identified many single-nucleotide polymorphisms (SNPs) that are associated with cardiovascular disease and its major risk factors in adults. [11] [12] [13] One GWAS among a total sample of around 16 000 adults identified 2 SNPs related to LVEDD and 5 SNPs related to AoD. 11 Two other GWAS, each with a total sample size of >120 000 adults, have identified 29 SNPs related to systolic blood pressure (SBP) or diastolic blood pressure (DBP), 22 SNPs related to mean arterial blood pressure (MAP), and 10 SNPs related to pulse pressure (PP). 12, 13 Not much is known about the influence of these SNPs on cardiovascular outcomes in childhood.
We hypothesized that common genetic variants associated with these subclinical cardiovascular outcomes in adults influence these outcomes from childhood onwards. Therefore, we examined the associations of known genetic variants for cardiac and blood pressure outcomes, identified in adults, with the same outcomes in children. We assessed the role of each SNP individually and of the SNPs combined in trait-specific genetic risk scores.
Methods

Study Design and Population
This study was embedded in the Generation R Study, a population-based, prospective cohort study from fetal life onwards. Pregnant women with an expected delivery date between April 2002 and January 2006 and living in the city of Rotterdam, The Netherlands, were eligible to participate. A detailed design of study has been described previously. 14 Generation R is a multiethnic cohort study, with participants of European origin constituting the largest ethnic group (56%). The largest other ethnic subgroups are Surinamese (9%), Turkish (7%), and Moroccan (6%). 14 The study has been approved by the local Medical Ethics Committee and written consent was obtained for all participating children. In total, 6690 children participated in the follow-up visits at the age of 6 years. After exclusion of twins, children with congenital cardiac and renal abnormalities and those without genome-wide association scans (GWAs) data, there were 4137 children who had information on at least 1 of the outcomes under study, of which 3890 with cardiac ultrasound data and 3927 with data on blood pressure. These numbers are shown in our flow chart ( Figure I in the Data Supplement).
Genetic Variants
DNA was extracted from cord blood according to a standardized protocol. If a cord blood sample was unavailable, DNA was isolated from blood samples taken at the 6-year visit (in 6% of our participants). GWAs were run using the Illumina 610 Quad or 660 platforms. Before imputation, SNPs were excluded if they had high levels of missing data (SNP call rate <98%), strong departures from Hardy-Weinberg equilibrium (P<1×10 -6 ), or low minor allele frequencies (<1%). MACH (version 1.0.15) software was used to impute genotypes to the HapMap II (release 22) cosmopolitan panel. 15, 16 We selected SNPs reported to be significantly associated with each of the outcomes in the combined discovery and replication analyses of recently published large GWAS in adults of European ancestry. Based on previous studies, we included 2 SNPs for LVEDD, 5 SNPs for AoD, 29 SNPs for SBP, 29 SNPs for DBP, 22 SNPs for MAP, and 10 SNPs for PP. [11] [12] [13] Genotypes for the SNPs of interest were extracted from the imputed GWAs data set. The mean quality of the imputed genotypes (r²) of SNPs included in this study was 0.96, ranging from 0.59 to 1.00. Fifty five of the 56 SNPs of interest had an r²>0.8. One SNP, rs10852932, was not present in our GWAs data set and was replaced by rs216223 (R²=1, D′=1).
Cardiovascular Outcomes
All cardiovascular and blood pressure outcomes under study were measured at the follow-up visit at the age of 6 years. Detailed methods of the cardiovascular measurements have been described previously. 17 Briefly, 2-dimensional M-mode echocardiography was performed using an ATL-Philips Model HDI 5000 (ATL-Philips, Seattle, WA) or Logiq E9 (GE Medical Systems, Wauwatosa, WI) device to measure LVEDD, end-diastolic interventricular septum thickness, left ventricular posterior wall thickness, left atrial diameter, and AoD. Participants with values <0.1% and >99.9% of the distribution for cardiac measurements (n=3) were excluded from the analyses. SBP and DBP were measured at the right brachial artery, 4× at 1-minute interval using a validated automatic sphygmomanometer (Datascope Accutorr PlusTM [Accutorr Plus, Paramus, NJ]). We calculated MAP (DBP+[(SBP−DBP)/3]) and PP (SBP−DBP) for each measurement. The means of the last 3 measurements were used for analyses. If only 3 successful blood pressure measurements were available (n=123), the means of these 3 were used in the analyses of the blood pressure outcomes. Participants with fewer than 3 successful blood pressure measurements were not included (n=210).
Covariates
Height and weight were measured without shoes and heavy clothing, and body mass index (kg/m 2 ) was calculated. Height was measured to the nearest 0.1 cm by a stadiometer (Holtain Limited, Crosswell, Crymych, United Kingdom). Weight was measured to the nearest gram using an electronic scale (SECA 888, Almere, The Netherlands).
Statistical Analysis
First, we analyzed the associations of all SNPs individually with their specific childhood outcomes, using linear regression models assuming an additive genetic model. Second, for each outcome, we calculated the percentage of variance explained by all SNPs combined by comparing the adjusted R 2 between a model including all SNPs and the covariates and a model including only the covariates. Third, for those outcomes for which >2 known adult SNPs were available (AoD, SBP, DBP, MAP, and PP), we combined the SNPs into weighted and unweighted genetic risk score and assessed the associations of these scores with the relevant outcomes using linear regression models. The weighted risk scores were computed as sums of the number of outcome-increasing alleles, reflected by the dosage of the SNP, weighted by their effect sizes derived from the adult GWAS. [11] [12] [13] In line with the adult study, all 29 SNPs related to either SBP, or DBP, or both were incorporated into a single weighted genetic risk score, indicated as weighted adult blood pressure genetic risk score, and weighted by the average of the SBP and DBP effect estimates in adults. 12 We rescaled each weighted risk score to a score ranging from zero to the maximum number of outcome-increasing alleles, rounded to the nearest integer. The unweighted genetic risk scores were computed by the sum of outcome-increasing alleles. Each blood pressure related genetic risk score was tested for association with all childhood blood pressure outcomes.
Although 5 individual SNPs were tested for AoD, the calculation of percentage of variance explained and the AoD risk scores were based on only 4 of these, as rs216223 and rs4523957 were in strong linkage disequilibrium (R²=0.81). Only rs216223, the SNP with the lowest P value in the original article, was included in these specific analyses. 11 The SNPs included in the genetic risk scores were not in linkage disequilibrium, except for rs4373814 and rs1813353 in the blood pressure risk scores, which were in low linkage disequilibrium with an R 2 of 0.015. All analyses were first performed in the full cohort as the primary analysis. As a sensitivity analysis, we subsequently repeated all analyses in European participants only, as this was the largest subgroup and because the included SNPs were identified in European adults. A child was classified as European if he/she was within 4 SD from the HapMap CEU panel mean value for all first 4 principal components based on the genetic data. The other ethnic subgroups were too small (n<287) to analyze separately. All regression models were adjusted for age, sex, and the first 4 principal components for either the full group or Europeans, with additional adjustment for height, weight, ultrasonographer, and ultrasound device used in the analyses of the cardiac outcomes and for age 2 and body mass index z scores in the analyses of the blood pressure outcomes. These covariates were chosen with the aim of using the same models as the adult studies, with the exception of ultrasonographer and ultrasound device which are Generation R study-Specific. [11] [12] [13] To adjust for multiple testing, we applied Bonferroni correction for the number of individuals SNPs per outcome and for the number of tested outcomes in the analyses of weighted genetic risk scores. All statistical analyses were performed using Statistical Package for the Social Sciences version 21.0 for Windows (SPSS, Chicago, IL).
Results
Subject Characteristics
Child characteristics for all children and European participants only are presented in Table 1 and in Table I in the Data Supplement, respectively.
Cardiac Outcomes
For LVEDD, 2 SNPs were analyzed, which showed no association with childhood LVEDD. Combined, these 2 SNPs explained <0.01% of the phenotypic variance in childhood LVEDD ( Table II in the Data Supplement) . For AoD, we analyzed 5 SNPs, of which rs4026608, rs10770612, and rs4523957 were associated with childhood AoD (all P values <0.01). Four of the 5 SNPs combined explained 0.5% of the phenotypic variance (Table II in the Data Supplement). The weighted adult AoD genetic risk score was associated with childhood AoD (Figure 1 ). Each additional weighted adult AoD-risk allele was associated with a 0.09 mm (95% confidence interval (CI): 0.05, 0.13) increase in childhood AoD. This risk score explained 0.4% of the phenotypic variance.
The unweighted genetic risk score for adult AoD was also associated with childhood AoD, yielding a 0.09 mm (95% CI: 0.05, 0.13) increase of AoD per additional average risk allele.
Blood Pressure Outcomes
Of the 29 SNPs related to adult blood pressure, none were individually associated with childhood SBP or DBP. All 29 SNPs combined explained 0.5% and <0.01% of the phenotypic variance for childhood SBP and DBP, respectively (Tables III and  IV in the Data Supplement). Neither the adult-weighted nor the unweighted blood pressure genetic risk scores were associated with any of the childhood blood pressure outcomes (Tables 2and 3; Figure 2A and 2B; Figure II in the Data Supplement).
Of the 22 SNPs related to adult MAP, none were individually associated with childhood MAP. All SNPs combined explained 0.2% of the phenotypic variance in MAP ( Table  V in the Data Supplement). Neither the weighted nor the unweighted MAP genetic risk scores were associated with any of the childhood blood pressure outcomes (Tables 2and 3; Figure 2C ; Figure III in the Data Supplement).
Of the 10 SNPs related to adult PP, none were individually associated with childhood PP. The 10 SNPs combined explained 0.3% of the variance in PP (Table VI in the Data Supplement). The weighted genetic risk score for adult PP was associated with childhood PP, with a difference in PP of 0.22 mm Hg (95% CI: 0.08, 0.35) per additional average risk allele and showed borderline significance with childhood SBP with a difference in SBP of 0.21 mm Hg (95% CI: 0.04, 0.37) per additional average PP-risk allele ( Table 2 ; Figure 2D ; Figure IVA in the Data Supplement). The weighted genetic risk score for adult PP was not associated with childhood DBP and MAP ( Figure IVB and IVC in the Data Supplement). The unweighted genetic risk score for adult PP was also associated with childhood PP. Each additional PP-risk allele increased childhood PP by 0.18 mm Hg (95% CI: 0.05, 0.31; Table 3 ).
Sensitivity Analysis Among Europeans Only
Overall, the results of the sensitivity analyses in Europeans only were largely in line with those in the full group, although the magnitude of the effect estimates differed between the groups. A noticeable difference was the phenotypic variance in the outcomes explained by the SNPs. Both individually and combined, the SNPs explained a larger part of the variance in LVEDD and AoD in Europeans than in the full group (Table II in (Tables III and V in the Data Supplement). The weighted adult AoD genetic risk score was also associated with childhood AoD in Europeans, with a difference in AoD of 0.12 mm (95% CI: 0.07, 0.18) per additional average risk allele and explained a larger part of the phenotypic variance in childhood AoD than in the full group (0.7% versus 0.4%; Table II; Figure V in the Data Supplement). The unweighted genetic risk score for adult AoD was also Diastolic blood pressure, mm Hg 61 (7) Mean arterial pressure, mm Hg 75 (7) Pulse pressure, mm Hg 42 (7) Diastolic interventricular septum thickness, mm 6 (1)
End-diastolic left ventricular diameter, mm 37 (3) Diastolic left ventricular posterior wall thickness, mm 6 (1)
Left atrial diameter, mm 25 (3) Aortic root diameter, mm 19 (2) Left ventricular mass, g 54 (11) Data are shown as mean (SD), except for male sex and ethnicity, which are number (%). Bpm indicates beats per minute. The left y axis represents the number of children in each risk score category, shown in the histogram. The P value is derived from the analysis of the continuous risk score as presented in Table 2 . associated with childhood AoD in Europeans, yielding a 0.12 mm (95% CI: 0.07, 0.18) increase in AoD per additional average risk allele. None of the weighted or unweighted genetic risk scores for blood pressure traits were associated with any of the childhood blood pressure traits in Europeans only (Tables VII and VIII in the Data Supplement).
Discussion
In this study, we observed that genetic risk scores based on genetic variants for AoD and PP in adulthood were also associated with the same outcomes in children at school age. Furthermore, the majority of the individual SNPs for adult AoD were also associated with childhood AoD. Regression coefficients (95% CI) derived from the linear regression models represent the change in outcome measure per additional weighted risk allele. Bonferroni corrected P value cutoff=0.013. BP indicates blood pressure; CI, confidence interval; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure; and var. expl., variance in the outcome explained by the risk score. Table 2 . The adult blood pressure genetic risk score was based on all 29 single-nucleotide polymorphisms related to systolic blood pressure, diastolic blood pressure, or both.
Interpretation of Main Findings
Left cardiac structures and function measures and blood pressure are predictors of cardiovascular disease risk. [18] [19] [20] Longitudinal studies showed that both cardiac and vascular risk factors are partly established in early life and track from childhood to adulthood. [1] [2] [3] [4] Although environmental and lifestyle related factors are important, heritability estimates suggest a partially genetic background for cardiovascular risk factors. [5] [6] [7] [8] [9] [10] Large scale GWAS among a total sample of ≈16 000 adults identified SNPs related to LVEDD and AoD, whereas other GWAS among >120 000 adults identified SNPs related to SBP, DBP, MAP, and PP. [11] [12] [13] We examined whether genetic variants associated with subclinical cardiovascular outcomes in adults influence these outcomes from childhood onwards. A larger AoD is associated with the risk of cardiovascular disease. 19 A previous study in adults suggested that the risk of cardiovascular disease increases ≈1.5×for each 10 mm increase in AoD. 19 We observed that a genetic risk score based on 4 SNPs related to AoD in adults was also associated with childhood AoD. Each additional average risk allele in the adult AoD risk score increased childhood AoD by 0.09 mm in the full group. In this perspective, the risk alleles incorporated in our risk score for AoD only exert a small effect on the risk of later life cardiovascular disease. Of the 5 analyzed SNPs for AoD, rs4026608, rs10770612, and rs4523957 were associated with childhood AoD. Rs4026608 lies near HMGA2, a gene implicated in the pathogenesis of aortic dissection and associated with body height, birth weight, and type 2 diabetes mellitus in GWAS. [21] [22] [23] [24] The nearest gene to rs10770612 is PDE3A, a gene expressed in human aortic smooth muscle cells. 25 Mice in which PDE3A has been knocked out display diminished growth and decreased proliferation of vascular smooth muscle cells. 26 In GWAS, SNPs close to PDE3A have been associated with levels of adiponectin and high-density lipoprotein cholesterol. 27, 28 Rs4523957 lies in the SRR gene which encodes an enzyme, serine racemase, which converts l-serine into d-serine. 29 SRR is strongly expressed in the brain, but also in human cardiac myocytes. 29 Studies in rats suggest an antihypertensive effect of L-serine. 30, 31 GWAS have associated SNPs in SRR to coronary artery disease. 32 We did not find an association of the blood pressure genetic risk score with childhood SBP. In contrast to our findings, a recent study examining the association of a risk score, based on the same SNPs for adult blood pressure as ours, with trajectories of SBP in children observed an association of the risk score with SBP in children at the age of 6 years. 33 A possible explanation for this discrepancy is the larger sample size of the previous study (n=8472), which in addition was completely European. Whereas our risk score was based on genome-wide significant SNPs only, another previous study used a broader, genome-wide profiling approach, also including many nongenome-wide significant adult SNPs, and did find an association of their adult risk score with childhood blood pressure. 34 Our approach of only using genome-wide significant SNPs may be more limited in detecting overlapping genetic loci that may be just below the significance cutoff in adults. The percentage of variance in childhood SBP explained by all 29 SNPs combined was almost twice as high in the full group when compared with Europeans, which suggests a relatively stronger effect of at least some of these SNPs in non-Europeans. A similar pattern has been observed in adults, where most SNPs for SBP identified in Europeans tended to have a larger effect estimate in East Asians than in Europeans. 12 For comparability with previous work, 12 we combined the 29 SNPs associated with either SBP, or DBP, or both into a single genetic risk score using the averages of the effect sizes for SBP and for DBP as the weights. Analyses using SBP-or DBP-specific SNPs showed similar results to those for the combined score (data not shown).
The genetic risk scores for PP were associated with childhood PP. In our study, PP was 1.1 mm Hg higher in children in the highest category of the risk score for PP compared with those in the lowest. In adults, a 10 mm Hg increase in PP is associated with an ≈ 20% higher risk of cardiovascular events. 35, 36 Heritability estimates of the traits under study range from 30% to 60%, 5-10 yet the percentage of variance explained by both the individual SNPs and the genetic risk scores was modest in our study. Rare genetic variants, potentially with larger effects, epigenetic factors and gene-environment interaction may account for this difference. Further large meta-analyses of genetic and epigenetic data are needed to shed light on this.
The findings for the unweighted genetic risk scores were analogous to those for the weighted genetic risk scores. The slight differences may be explained by the fact that the relative weights of individual SNPs may vary across the life course and weighting based on betas from studies in adults may not Regression coefficients (95% CI) derived from the linear regression models represent the change in outcome measure per additional weighted risk allele. Bonferroni corrected P value cutoff=0.013. BP indicates blood pressure; CI, confidence interval; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure; and var. expl., variance in the outcome explained by the risk score.
adequately reflect weights in children. Although all significant individual SNPs were directionally consistent to those in adults, effect estimates differed strongly between adults and children, which reflect that relative contributions of risk variants may differ with age. 11 Our findings indicate that the genetic mechanisms underlying development of cardiac and blood pressure outcomes have at least partial overlap between adults and children.
Methodological Considerations
The main strength of our study is the relatively large sample size of this prospective population-based cohort. Furthermore, detailed and validated measurements were used to measure cardiac structures and blood pressure. Some limitations also need to be addressed. Although this study was embedded in a large cohort of children, we still had limited power to detect associations for single SNPs, especially among Europeans. The majority of individual SNPs known to be associated with cardiac and blood pressure outcomes in adulthood were not associated with their related outcomes in childhood, likely reflecting this lack of power in our study. The adult GWAS studies were based on 16 000 to 120 000 adults, whereas our study was only based on 4137 children. Our full study population was heterogeneous because of its multiethnic nature. Although we adjusted for the first 4 principal components based on genetic data, there may be heterogeneity left. The main issues in this case are differences in allele frequency and in linkage disequilibrium structure between the ancestral groups. Combining samples of different ethnicities may have diluted the associations, but is less likely to have led to false-positive findings, as the majority of our group was of European ethnic background. Furthermore, the associations for almost all individuals SNPs and genetic risk scores were directionally consistent in the full group and the European group and confidence intervals overlapped, which indicates that most of these SNPs exert similar effects in both groups.
In population-based cohort studies such as ours, nonparticipation at baseline and loss-to-follow-up may play a role. The included study sample at birth consisted of 9901 children, corresponding to a response rate at baseline of 61%. 14 The participating sample had a slightly higher socioeconomic status and included a lower number of participants with medical complications than those not participating at baseline. This may influence the generalizability of our results. A total of 6690 children participated in the follow-up visit at the age of 6 years. In 2347 singleton live born children without congenital cardiac or kidney abnormalities that visited the research center at age 6 years, GWAs data were not available. Compared with children with GWAs data, those without GWAs data had a lower birth weight and gestational age (3357 versus 3463 g; P<0.001 and 39.6 versus 40.0 weeks; P<0.001). However, the values for all cardiovascular outcomes were not statistically different between children with and without GWAs data (data not shown). Also, of all singleton live born children with GWAs data available (n=5687), 1534 children did not participate in the cardiovascular follow-up measurements. Compared with children with cardiovascular follow-up measurements, those without these measurements had a slightly lower birth weight (3428 versus 3463 g; P=0.03). We consider it unlikely that these differences would have influenced our findings.
Conclusions
Genetic risk scores based on adult SNPs for AoD and PP are associated with these same outcomes in children. Known SNPs related to cardiovascular outcomes in adulthood at least partly influence cardiovascular development from early life onwards. The relative effects of genetic variants on cardiovascular outcomes may vary throughout life.
CLINICAL PERSPECTIVE
Subclinical cardiovascular risk factors, such as increased blood pressure and changes in structural echocardiographic measurements, develop from childhood onwards and are heritable. Understanding the molecular background of these phenotypes will give insight into underlying (patho-) physiological mechanisms. Recent genome-wide association studies have identified single-nucleotide polymorphisms related to left ventricular end-diastolic diameter, aortic root diameter, systolic and diastolic blood pressure, mean arterial pressure, and pulse pressure in adults. Little is known about the influence of these single-nucleotide polymorphisms on subclinical cardiovascular phenotypes during childhood. We examined in a populationbased prospective cohort study among 4137 children the associations of these known genetic variants for echocardiographic and blood pressure traits, identified in adults, with the same traits in children at the age of 6 years. We assessed the role of each single-nucleotide polymorphism individually and of the single-nucleotide polymorphisms combined in trait-specific genetic risk scores. We observed that genetic risk scores for adult aortic root diameter and pulse pressure were associated with their respective childhood phenotypes. Our findings indicate that the genetic basis of subclinical cardiovascular phenotypes at least partly overlaps between adults and children.
